LSL Pharma Group, Inc. (LSL.V)
0.335
-0.02
(-4.29%)
CAD |
TSXV |
Aug 25, 16:00
LSL Pharma Group Debt to Equity Ratio : 2.302 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 2.302 |
| March 31, 2026 | 1.808 |
| December 31, 2025 | 1.422 |
| September 30, 2025 | 1.139 |
| June 30, 2025 | 1.152 |
| March 31, 2025 | 0.9335 |
| December 31, 2024 | 0.8692 |
| September 30, 2024 | 0.6894 |
| June 30, 2024 | 0.7024 |
| March 31, 2024 | 0.8937 |
| December 31, 2023 | 1.802 |
| September 30, 2023 | 1.616 |
| Date | Value |
|---|---|
| June 30, 2023 | 1.247 |
| March 31, 2023 | 1.101 |
| July 31, 2022 | -0.0962 |
| April 30, 2022 | -0.1204 |
| January 31, 2022 | -0.1244 |
| October 31, 2021 | -0.1335 |
| July 31, 2021 | -0.1346 |
| April 30, 2021 | -0.1715 |
| January 31, 2021 | -0.2131 |
| October 31, 2020 | -0.2583 |
| July 31, 2020 | -0.2629 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Vitality Products, Inc. | -0.47 |
| Genix Pharmaceuticals Corp. | -0.497 |
| Leef Brands, Inc. | -6.090 |
| NeutriSci International, Inc. | -- |
| Jamieson Wellness, Inc. | 0.9369 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 87.07M |
| Total Liabilities (Quarterly) | 65.10M |
| Shareholders Equity (Quarterly) | 21.98M |
| Current Ratio | 1.155 |
| Net Debt Paydown Yield | -13.77% |